Sovaldi, a once-daily nucleotide analog polymerase inhibitor, is indicated for use in combination with ribavirin (RBV) for 12 weeks and the combination is the first all-oral, interferon-free treatment
The collaboration will help people with Type 1 or Type 2 diabetes to talk to their health care professional (HCP) about these diseases. Merck medical director Mel Kohn
According to the company, Novoeight provides purity, reliability and improved portability, with the highest storage temperature for the longest period of time compared with other marketed recombinant Factor
Encruse is a long-acting muscarinic antagonist (LAMA), a type of bronchodilator which can relax airway muscles and improve airflow in and out of the lungs. The company said
SIG990 is claimed to have the potential to both reduce erythema and decrease the papules and pustules associated with the disease. The company has already secured approval for
The Docetaxel injection is designed to treat breast cancer, non-small cell lung cancer, prostate cancer, gastric adenocarcinoma, and head and neck cancer. TPU executive VP and chief operating
Currently, the company is conducting a Phase II trial evaluating the safety and efficacy of ganaxolone as adjunctive therapy for uncontrolled seizures in PCDH19 female pediatric epilepsy, and
In July 2014, the company has secured orphan drug designation from the US Food and Drug Administration (FDA) for RG-012 to treat Alport syndrome. Currently, the company is
Currently, MBX-8025 is being evaluated in high unmet need and orphan diseases. HoFH is characterized by loss-of-function mutations in both alleles of the LDL receptor (LDL-R) gene and
The approval is based on data from a pivotal multicenter, randomized, controlled, Phase III trial designed to compare the safety and immunogenicity of Quadracel vaccine with DAPTACEL (DTaP)
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.